Cover Image

Woronoff Ring in Deficiency of Interleukin-36 Receptor Antagonist (DITRA)

Saved in:

Bibliographic Details
Main Authors:	Daniel Morgado-Carasco (Author), Sebastian Podlipnik (Author), José M. Mascaró Jr (Author)
Format:	Book
Published:	Mattioli1885, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
by: Toni Hospach, et al.
Published: (2019)

Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series
by: Chang-Yu Hsieh, et al.
Published: (2024)

Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin
by: Edwin Cuperus, MD, et al.
Published: (2018)

The Woronoff Ring in Psoriasis and the Mechanisms of Postinflammatory Hypopigmentation
by: Jörg C. Prinz
Published: (2020)

Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
by: Francisco Gómez-García, et al.
Published: (2018)

A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
by: Chiharu Tominaga, et al.
Published: (2015)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
by: Hachulla E, et al.
Published: (2011)

Successful treatment of recalcitrant generalized pustular psoriasis in a young child with interleukin-36 receptor antagonist mutation with secukinumab monotherapy
by: Henrietta Albela, et al.
Published: (2021)

Dermoscopic Features of Chondrodermatitis Nodularis Chronica Helicis: A Case Series
by: Daniel Morgado-Carasco, et al.
Published: (2019)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
by: P. Bjrök, et al.
Published: (1992)

Interleukin-17 receptor antagonist reduces inflammatory response in experimental periodontitis
by: Dr Takenori Sato, et al.
Published: (2023)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
by: L. Riente
Published: (2011)

Mitoprotective effect of the receptor antagonist interleukin-1 in experimental cerebral stroke
by: E. V. Suprun
Published: (2012)

Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size
by: Isaline Renard, et al.
Published: (2024)

A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)
by: Leonardo Oliveira Mendonça, et al.
Published: (2020)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
by: Queenie Hui, et al.
Published: (2017)

Usefulness of interleukin 1 receptor antagonist (anakinra) in refractory post-pericardiotomy syndrome
by: Marta Flores Fernández, et al.
Published: (2021)

The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
by: G. S. Smith, et al.
Published: (1996)

Role of interleukin-36 in kidney disease
by: Bi-xia Yang, et al.
Published: (2023)

Important Roles of Interleukin-36, Interleukin-37, and Interleukin-38 Cytokines in the Pathogenesis of Rosacea
by: Alper Ekinci, et al.
Published: (2024)

Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects
by: Yung-Yean Kok, et al.
Published: (2017)

Association of C-Reactive Protein, Interleukin-1 Receptor Antagonist and Adiponectin with the Metabolic Syndrome
by: Esko Kumpusalo, et al.
Published: (2007)

Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
by: Nicole Armbruster, et al.
Published: (2017)

Minimally-invasive Sampling of Interleukin-1α and Interleukin-1 Receptor Antagonist from the Skin: A Systematic Review of In vivo Studies in Humans
by: Denise Falcone, et al.
Published: (2017)

Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3
by: Yang Liu, et al.
Published: (2019)

Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonist
by: Hollister J Roger, et al.
Published: (2009)

Imbalance between serum interleukin-36 and interleukin-38 is associated with metabolic syndrome in psoriasis vulgaris
by: Marwa A Amer, et al.
Published: (2023)

Association of interleukin-36α and interleukin-38 with type 2 diabetes mellitus and diabetic neuropathy
by: Shahad W. Nassurat, et al.
Published: (2024)

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017)

A Randomized Controlled Trial of Interleukin-1 Receptor Antagonist in a Rabbit Model of Ascending Infection in Pregnancy
by: Robert S. McDuffie, et al.
Published: (2001)

Interleukin (IL)-1B and IL-1 receptor antagonist gene polymorphisms in children with primary immune thrombocytopenia
by: Seham Mohamed Ragab, et al.
Published: (2024)

Selection of excipients for the purpose of creating an intranasal gel of interleukin-1 receptor antagonist β (IL-1ra)
by: B. S. Burlaka, et al.
Published: (2020)

Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology
by: Andrew D. Greenhalgh, et al.
Published: (2012)

Pharmacokinetics and Anti-asthmatic Potential of Non-parenterally Administered Recombinant Human Interleukin-1 Receptor Antagonist in Animal Models
by: Ting Li, et al.
Published: (2006)

Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist
by: Jia Deng, et al.
Published: (2022)

Recombinant production of interleukin-1 receptor antagonist in fusion to albumin binding domain with potential affinity to human serum albumin
by: Fatemeh Shafiee, et al.
Published: (2024)

High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype
by: S. Ramírez-Pérez, et al.
Published: (2017)

Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist
by: Zeft Andrew S, et al.
Published: (2012)

Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
by: Semra Eroglu, et al.
Published: (2021)

On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding
by: Daniel Hoyer, et al.
Published: (2024)